Affinity Capital Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-433
| Closed | -$3.51K | – | 139 |
|
|
2023
Q1 | $3.51K | Buy |
433
+65
| +18% | +$528 | ﹤0.01% | 123 |
|
|
2022
Q4 | $4.37K | Buy |
368
+68
| +23% | +$807 | ﹤0.01% | 108 |
|
|
2022
Q3 | $4K | Buy |
300
+112
| +60% | +$1.49K | ﹤0.01% | 106 |
|
|
2022
Q2 | $7K | Hold |
188
| – | – | ﹤0.01% | 108 |
|
|
2022
Q1 | $8K | Hold |
188
| – | – | ﹤0.01% | 113 |
|
|
2021
Q4 | $8K | Hold |
188
| – | – | ﹤0.01% | 122 |
|
|
2021
Q3 | $13K | Buy |
+188
| New | +$13K | ﹤0.01% | 120 |
|